News

Admittedly, finding the silver lining in tough situations demands mental fortitude, and can require a reasonably positive ...
Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...
Parex Resources Inc. ("Parex" or the "Company") is pleased to announce its financial and operating results for the three-month period ended March 31, 2025, the declaration of its Q2 2025 regular ...
We also see this as an excellent artifact with which to promote collaboration within and between communities: the principle we endorse ... as small interfering RNA (siRNA) or small chemical ...
Also in March 2025, Wave announced that the company met with the U.S. Food and Drug Administration (FDA) on WVE-N531 to ...
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
Several human pathogens exploit the kinetic forces generated by polymerizing actin to power their intracellular motility. Human cell-autonomous immune responses activate ...
The Department of Justice has reached an agreement in principle to settle a lawsuit brought by the family of Ashli Babbitt, a pro-Trump rioter who was shot by a U.S. Capitol Police officer during ...
The Trump administration has reached a financial settlement “in principle” with the family of Ashli Babbitt, a member of the mob that stormed the U.S. Capitol on Jan. 6 who was shot and killed ...
The Justice Department said Friday that a “settlement in principle” has been reached with rioter Ashli Babbitt’s family to resolve a lawsuit they filed over her death during the Jan. 6 ...